The efficacy of tretinoin gel 0.1% followed by topical minoxidil-5% in individuals with androgenetic alopecia

Authors

  • B. S. Chandrashekar Department of Dermatology, CUTIS Academy of Cutaneous Sciences, Vijayanagar, Bangalore, Karnataka, India https://orcid.org/0000-0001-9593-8875
  • N. G. Nayana Department of Dermatology, CUTIS Academy of Cutaneous Sciences, Vijayanagar, Bangalore, Karnataka, India
  • M. S. Roopa Department of Clinical Research, CUTIS Academy of Cutaneous Sciences, Vijayanagar, Bangalore, Karnataka, India
  • N. Lakshmi Narayana Department of Clinical Research, CUTIS Academy of Cutaneous Sciences, Vijayanagar, Bangalore, Karnataka, India

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20252067

Keywords:

Androgenetic alopecia, Minoxidil, Tretinoin, Hair growth, Combination therapy

Abstract

Androgenetic alopecia (AGA) is a progressive hair loss condition, with a higher prevalence among males aged 30-50 years in the Indian population. Minoxidil, a topical treatment, is commonly used but shows variable efficacy, particularly in non-responders. Recent studies suggest that combining minoxidil with tretinoin may enhance its effectiveness by increasing scalp absorption and improving hair follicle activity. This case series included 20 patients with AGA (male Norwood-Hamilton grades II-V and female Ludwig grades I-II), clinically diagnosed as non-responders to minoxidil. Participants received a combination therapy of 0.1% tretinoin gel and 5% minoxidil solution over 90 days. Improvements were observed in trichoscopic parameters where 32.9% increase in hair count and density, 3.5% rise in anagen-phase hairs, and 4.8% increase in hair thickness. Investigator global photography assessments revealed 20% of participants showed 51-75% improvement. Advanced AGA grades showed partial reversal. Patient self-assessments indicated 50% improvement in hair quality, 70% in hair coverage, and 75% in overall appearance. Most participants reported new hair growth (80%) and satisfaction with treatment. The combination of 0.1% tretinoin gel and 5% minoxidil demonstrated efficacy in improving hair growth and patient satisfaction in AGA patients who are non- responder to minoxidil.

Metrics

Metrics Loading ...

References

Shankar DK, Chakravarthi M, Shilpakar R. Male androgenetic alopecia: Population-based study in 1,005 subjects. Int J Trichol. 2009;1:131-3. DOI: https://doi.org/10.4103/0974-7753.58556

Mantovani GP, Marra C, De Maria F, Pinto V, De Santis G. Adipose-derived stromal vascular fraction (SVF) for the treatment of androgenic alopecia (AGA): a systematic review. Acta Biomed. 2023;94(5):e2023236.

Shadi, Z. Compliance to Topical Minoxidil and Reasons for Discontinuation among Patients with Androgenetic Alopecia. Dermatol Ther (Heidelb). 2023;13:1157-69. DOI: https://doi.org/10.1007/s13555-023-00919-x

Dhurat R, Daruwalla S, Pai S. SULT1A1 (Minoxidil Sulfotransferase) enzyme booster significantly improves response to topical minoxidil for hair regrowth. J Cosmet Dermatol. 2021;00:1-4. DOI: https://doi.org/10.1111/jocd.14299

Goren A, Castano JA, McCoy J, Bermudez F, Lotti T. Novel enzymatic assay predicts minoxidil response in the treatment of androgenetic alopecia. Dermatol Therap. 2013;27(3):171-3. DOI: https://doi.org/10.1111/dth.12111

Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019;13:2777-86. DOI: https://doi.org/10.2147/DDDT.S214907

Sharma A, Goren A, Dhurat R, Agrawal S, Sinclair R, Trüeb RM, et al. Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes. Dermatol Ther. 2019;32(3):e12915. DOI: https://doi.org/10.1111/dth.12915

Shin HS, Won CH, Lee SH, Kwon OS, Kim KH, Eun HC. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial. Am J Clin Dermatol. 2007;8(5):285-90. DOI: https://doi.org/10.2165/00128071-200708050-00003

Zarkesh K, Khazaeli P, Pardakhty Abbas and Rezaifar M. Preparation and Physicochemical Characterization of Topical Niosomal Formulation of Minoxidil and Tretinoin. Global J Pharmacy Pharmaceut Sci. 2017;3(2):21-6. DOI: https://doi.org/10.19080/GJPPS.2017.03.555606

Voorhees JJ. Clinical effects of long-term therapy with topical tretinoin and cellular mode of action. J Int Med Res. 1990;18:26-8.

Ferry JJ, Forbes KK, VanderLugt JT, Szpunar GJ. Influence of tretinoin on the percutaneous absorption of minoxidil from an aqueous topical solution. Clin Pharmacol Therapeut. 1990;47:439-46. DOI: https://doi.org/10.1038/clpt.1990.55

Kwon OS, Pyo HK, Oh YJ, Han JH, Lee SR, Chung JH, et al. Promotive effect of minoxidil combined with all-trans retinoic acid (tretinoin) on human hair growth in vitro. J Korean Med Sci. 2007;22(2):283-9. DOI: https://doi.org/10.3346/jkms.2007.22.2.283

Yoo HG, Chang IY, Pyo HK, Kang YJ, Lee SH, Kwon OS, Cho KH, Eun HC, Kim KH. The additive effects of minoxidil and retinol on human hair growth in vitro. Biol Pharm Bull. 2007;30(1):21-6. DOI: https://doi.org/10.1248/bpb.30.21

Pratiksha K, Nayak K, Thakkar S, Polaka S, Khunt D, Misra M. Exploring the Potential of Minoxidil Tretinoin Liposomal Based Hydrogel for Topical Delivery in the Treatment of Androgenic Alopecia. Cutaneous Ocular Toxicol. 2020;39(1):43-53. DOI: https://doi.org/10.1080/15569527.2019.1694032

Downloads

Published

2025-06-27

How to Cite

Chandrashekar, B. S., Nayana, N. G., Roopa, M. S., & Narayana, N. L. (2025). The efficacy of tretinoin gel 0.1% followed by topical minoxidil-5% in individuals with androgenetic alopecia. International Journal of Research in Dermatology, 11(4), 303–307. https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20252067